Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cadonilimab Combined With Radical Radiotherapy in Locally Advanced Cervical Cancer Patients Ineligible for Concurrent Chemotherapy - A Prospective, Single Arm, Phase II Trial

NCT07450963 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07450963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07450963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cadonilimab Combined With Radical Radiotherapy in Locally Advanced Cervical Cancer Patients Ineligible for Concurrent Chemotherapy - A Prospective, Single Arm, Phase II Trial
Lead sponsor
Ruijin Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
February 28, 2034
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced cervical cancer